License granted for new DHA microalgae process

By Jess Halliday

- Last updated on GMT

The European inventors of a process for deriving higher yields of
DHA (docosahexaenoic acid) from microalgae have licensed the patent
to Advanced BioNutrition - a deal that could ultimately impact the
human nutrition market for DHA.

The exclusive worldwide license allows the company to use the oil resulting from the process in whatever market it chooses. ABN's core business in animal nutrition, so this will be the first area of development.

However a spokesperson for the company told NutraIngredients-USA.com that it would "absolutely"​ consider a sub-license to allow another company to take the oil into human nutrition.

The fermentation process using the microalgae Crypthecodinium cohnii​ was invented by scientists at the University of Hull in the UK and Wageningen University's Agrotechnology & Food Sciences Group (AFSG), The Netherlands.

They were granted patents to the process in both the US and the UK last year.

Dr Lolke Sijtsma of AFSG, one of the scientists who collaborated on the project, explained that the higher yield is due to the use of acetic acid in place of glucose as the carbon source.

According to published data, the yield could be increased by a factor of three.

ABN's main counterpart in the human field is Martek Biosciences, like ABN based in Columbia, MD; it holds a clutch of patents in this area and also uses C. cohnii, as well as some other microalgae.

Martek has indicated that it is in discussions with major food companies to incorporate it into consumer products.

Last year it tweaked its production process so it could supply DHA at a lower cost - a move that was expected to make the intgredient more attractive for companies investigating its use in foods.

Moreover, Martek claims that its DHA and ARA are in 80% of US infant formulas. Licensees include Mead Johnson, Wyeth, Abbott Laboratories and Nestle.

The best source of DHA, an omega-3 fatty acid, has traditionally been fish oil. Consumer interest in omega-3 has skyrocketed in the last couple of years, largely thanks to positive research results supporting its health, especially in heart health, cognitive function and infant and maternal health. Martek markets its product on the basis of its vegetarian origin. Other vegetarian sources such as flax oil are considerably less bioavailable.

Related news

Show more

Related products

show more

Research for Restorative Sleep: Levagen®+

Research for Restorative Sleep: Levagen®+

Content provided by Gencor | 27-Sep-2024 | White Paper

Levagen®+ is Gencor's branded Palmitoylethanolamide (PEA), an endogenous fatty acid amide naturally found in every cell of the body.

Comprehensive Nutritional Lipid Solutions

Comprehensive Nutritional Lipid Solutions

Content provided by INNOBIO Corporation Limited | 24-Sep-2024 | White Paper

INNOBIO specializes in high-quality DurOmega® functional lipid products, emphasizing enhanced fatty acid quality and application performance.

Research for Restorative Sleep: Levagen®+

Research for Restorative Sleep: Levagen®+

Content provided by Gencor | 09-Sep-2024 | White Paper

Levagen®+ is Gencor's branded Palmitoylethanolamide (PEA), an endogenous fatty acid amide naturally found in every cell of the body.

Research to Reality: Restorative Sleep

Research to Reality: Restorative Sleep

Content provided by Gencor | 02-Sep-2024 | White Paper

Gencor prides itself on its cutting-edge, science-driven solutions. Explore sleep support through gold-standard, clinically-validated dietary supplement...

Related suppliers

Follow us

Products

View more

Webinars